Clinical Guideline InSights

Clinical Guideline InSights

By Guideline CentralMedicineHealth & Fitness
Download on the App Store

Clinical Guideline InSights episodes

  • ACR Management of Osteoarthritis of the Knee, Hip, and Hand 2026 - New and Updated Recommendations

    Update of the 2026 Management of Osteoarthritis of the Knee, Hip, and Hand, highlighting updated and new recommendations across massage therapy, methotrexate, and more.


    • Management of Osteoarthritis of the Knee, Hip, and Hand

    • American College of Rheumatology 

    • Full-Text:  https://assets.contentstack.io/v3/assets/bltee37abb6b278ab2c/bltb3d12c34020da842/oa-guideline-summary-2026.pdf 

    • InSights: https://www.guidelinecentral.com/insights/sep-2026-acr-osteoarthritis-guideline-spotlight/

    2 min
  • AHA Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management 2026 Scientific Statement

    The 2026 Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management scientific statement, highlighting key take-home points across diagnosis, treatment, and more. 


    • Infective Endocarditis: Diagnosis, Antibiotic Therapy, and Management

    • American Heart Association

    • September 8, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5263671/ 

    • Full-Text:  https://www.ahajournals.org/doi/10.1161/CIR.0000000000001466 

    12 min
  • AAP Prevention of Respiratory Syncytial Virus Disease in Infants and Children 2026 Policy Statement

    The 2026 Prevention of Respiratory Syncytial Virus Disease in Infants and Children policy statement, highlighting key recommendations across approved products, timing of administration, coadministration with routine childhood vaccines, and more. 


    • Prevention of Respiratory Syncytial Virus Disease in Infants and Children

    • American Academy of Pediatrics

    • September 2, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5257391/ 

    • Full-Text:  https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2026-079047/208784/Recommendations-for-the-Prevention-of-Respiratory 

    11 min
  • IDSA/ESCMID Staphylococcus aureus Bacteremia Risk Stratification, Diagnostic Evaluation & Management

    The 2026 Staphylococcus aureus Bacteremia: Risk Stratification, Diagnostic Evaluation, and Management of Adults and Children consensus statement, highlighting key consensus statements across risk stratification, transthoracic echocardiography, transesophageal echocardiography, whole body imaging, and more.


    • Staphylococcus aureus Bacteremia: Risk Stratification, Diagnostic Evaluation, and Management of Adults and Children

    • Infectious Diseases Society of America and European Society of Clinical Microbiology and Infectious Diseases

    • September 9, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5233364/ 

    • Full-Text:  https://www.idsociety.org/practice-guideline/staphylococcus-aureus-bacteremia/ 

    9 min
  • AACE Use of Diabetes Technology for Management of Adults with Diabetes 2026 Consensus Statement

    The 2026 Use of Diabetes Technology for Management of Adults with Diabetes consensus statement, highlighting key implementation considerations across automated insulin delivery systems, standardized work flows, continuous glucose monitoring, and more. 


    • Use of Diabetes Technology for Management of Adults with Diabetes

    • American Association of Clinical Endocrinologists

    • September 8, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5262095/ 

    • Full-Text:  https://www.endocrinepractice.org/article/S1530-891X(26)01046-3/fulltext 

    3 min
  • IDSA Use of Vaccines for the Prevention of COVID-19, Influenza & RSV in Immunocompromised Patients

    The 2026 Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients guideline, highlighting key recommendations.

     

    • Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients

    • Infectious Diseases Society of America

    • September 2, 2026

    • Guideline Summary:  https://www.guidelinecentral.com/guideline/4968637/ 

    • Full-Text:  https://www.idsociety.org/practice-guideline/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/ 

    2 min
  • AAD Diagnostic Testing in Adults with Presumed Atopic Dermatitis Refractory to Treatment Guideline

    The 2026 Diagnostic Testing in Adults with Presumed Atopic Dermatitis Refractory to Treatment, highlighting a summary of the good practice statement. 


    • Diagnostic Testing in Adults with Presumed Atopic Dermatitis Refractory to Treatment

    • American Academy of Dermatology

    • August 31, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5256681/ 

    • Full-Text:  https://www.jaad.org/article/S0190-9622(26)03145-2/fulltext 

    1 min
  • ACG Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes 2026 Guideline

    The 2026 Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes guideline, highlighting key recommendations across familial adenomatous polyposis, upper endoscopic surveillance of the duodenum, endoscopic ampullectomy, and more. 


    • Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes

    • American College of Gastroenterology

    • September 1, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5257284/ 

    • Full-Text:  https://www.ovid.com/jnls/ajg/fulltext/10.14309/ajg.0000000000004105~acg-clinical-guideline-diagnosis-and-management-of 

    6 min
  • ESC Management of Heart Failure 2026 Guideline – Key Messages Across Prevention, Diagnosis & More

    The 2026 Management of Heart Failure guideline, highlighting key messages across prevention of heart failure, diagnosis of heart failure, multidisciplinary management, and more. 


    • Management of Heart Failure

    • European Society of Cardiology

    • August 28, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5254699/ 

    • Full-Text:  https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302

    9 min
  • ESC Management of Cardiovascular Disease and Chronic Kidney Disease 2026 Guideline

    The 2026 Management of Cardiovascular Disease and Chronic Kidney Disease guideline, highlighting key messages across CKD screening, risk assessment, CVD management, and more. 


    • Management of Cardiovascular Disease and Chronic Kidney Disease

    • European Society of Cardiology

    • August 28, 2026

    • Guideline Summary: https://www.guidelinecentral.com/guideline/5254705/ 

    • Full-Text:  https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag098/8766283 

    9 min

About Clinical Guideline InSights

From the publisher's feed

Quick rapid summaries highlighting the latest guideline recommendations and updates published by medical societies.